Market Research Report
US Market for Bone Graft Substitutes 2011-2021
|Published by||iData Research Inc.||Product code||227848|
|Published||Content info||132 Pages
Delivery time: 1-2 business days
|US Market for Bone Graft Substitutes 2011-2021|
|Published: June 1, 2015||Content info: 132 Pages||
The bone graft substitute market consists of allograft, demineralized bone matrix and synthetic materials. Bone grafts are used in a variety of indications including spinal fusion, trauma, large joint reconstruction, foot reconstruction, as well as craniomaxillofacial and oncological applications.
The bone graft substitute market competes with both the growth factor market, which is currently only comprises INFUSE®, and the stem cell graft market. Due to the declining usage of INFUSE®, the use of bone graft substitute use has increased. The rise of cell therapy products, including platelet-rich-plasma and bone marrow concentrate, has also aided the growth of the bone graft substitute market, especially in the segments for demineralized bone matrices and synthetic grafts. Platelet-rich plasma provides growth factors when a graft is soaked in it; bone marrow concentrate provides stem cells. This complementary use allows bone graft substitutes to better compete with the growth factors and stem cell grafts.